Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy
Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight loss product Wegovy at a significantly reduced cost.
The drugmaker has named its new program NovoCare® Pharmacy, which will sell all dose strengths of Wegovy at $499 per month. According to the company, about 90 percent most patients pay a monthly copay of zero to $25 and this new program is aimed at eligible people who are uninsured or are on insurance plans that don't cover obesity medicines.
The list price for one month's supply of Wegovy is $1,349.
"NovoCare® Pharmacy expands the company's toolkit of offerings to meet the diverse needs of people living with obesity," the company said in a press release, noting this announcement comes on the heels of the Food and Drug Administration (FDA) recently confirming that both Wegovy and Ozempic, forms of the GLP-1 medication semaglutide, are no longer in shortage.
Wegovy is a form of semaglutide indicated specifically for weight loss. One group of insured individuals who may not be able to access it are Medicare beneficiaries as the federal insurance program is still currently prohibited from covering weight loss drugs. Medicare enrollees can receive coverage for the medication if it is prescribed for its other indication, the reduced risk of cardiovascular death, heart attack and stroke.
While Wegovy and Ozempic were both listed on the FDA's drug shortage list, compounding pharmacies were able to sell copycat versions of semaglutide at a significantly reduced price. These products were not FDA-approved and as such were not covered by insurers.
The agency's guidelines do provide some time for patients who were using compounded drugs to transition to the FDA-approved versions of the drugs and this new program from Novo Nordisk appears to cater to individuals who were accustomed to getting semaglutide at a reduced rate without insurance.
The cost of compounded versions of semaglutide sold by online telehealth providers ranged from $150 to $280 for a month's supply.
"Novo Nordisk continues to advance solutions for patients that improve affordability and access to our medicines, whether they have insurance or not. Today, over 55 million people in the U.S. have coverage specifically for weight management medicines, and 90% of Wegovy® patients with coverage pay $0 to $25 a month for Wegovy®," said Dave Moore, president of Novo Nordisk Inc.
Eli Lilly, the manufacturer of the GLP-1 drug tirzepatide, similarly made a move last year to offer its in-demand drug at a reduced cost by providing an option of buying it in single-dose vials instead of in autoinjectors.
-
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.CNBC - 11h -
Novo Nordisk goes direct to consumer with Wegovy. What it means for obesity rival Eli Lilly
Shares of Eli Lilly rose Wednesday despite its rival's announcement.CNBC - 12h -
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insuranceABC News - 11h -
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - Feb. 21 -
Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.MarketWatch - Feb. 25 -
FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on ...CBS News - Feb. 22 -
There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers
Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.MarketWatch - 16h -
Is the Future of the Creator Economy Direct-to-Consumer?
Confusion surrounding the TikTok ban last month has pushed creators to seek more stable ways to earn.Inc. - Feb. 21 -
Consumers turn to renting chickens as egg prices soar
As the bird flu outbreak impacts egg shortages and prices, some people are turning to renting or buying backyard chickens.CBS News - Feb. 21
More from The Hill
-
Walz calls Trump address 'reality TV'
Minnesota Gov. Tim Walz (D) on Wednesday slammed President Trump’s address to Congress in an interview on CNN, referring to the speech as “reality TV.” “Look, it was what I expected, it was reality ...The Hill - 2h -
New Mexico Democrat says 'This is not normal' sign at Trump address was 'an SOS to the world'
Rep. Melanie Stansbury (D-N.M.) said during an interview that her “This is not normal” sign she held up near President Trump right before his Tuesday night speech to Congress was an “SOS to the ...The Hill - 3h -
House Republicans gush over DOGE in meeting with Musk
Billionaire tech mogul Elon Musk met with House Republicans Wednesday night to update them on work done by the Department of Government Efficiency (DOGE), as the newly created group takes ...The Hill - 4h -
Is Social Security money going to 'millions' of people listed as old as 149?
Trump drew laughs during his congressional address Tuesday when he alleged that the Social Security Administration (SSA) had millions of beneficiaries listed at 140 years of age and older. But is ...The Hill - 4h -
GOP lawmaker holding town hall despite advice to avoid them: 'I trust my constituents'
Rep. Chuck Edwards (R-N.C.) said Wednesday he’s holding a town hall despite House Republicans being recently pushed to avoid in-person town halls and do phone or livestreamed ones instead. “I'm ...The Hill - 4h
More in Politics
-
Walz calls Trump address 'reality TV'
Minnesota Gov. Tim Walz (D) on Wednesday slammed President Trump’s address to Congress in an interview on CNN, referring to the speech as “reality TV.” “Look, it was what I expected, it was reality ...The Hill - 2h -
New Mexico Democrat says 'This is not normal' sign at Trump address was 'an SOS to the world'
Rep. Melanie Stansbury (D-N.M.) said during an interview that her “This is not normal” sign she held up near President Trump right before his Tuesday night speech to Congress was an “SOS to the ...The Hill - 3h -
House Republicans gush over DOGE in meeting with Musk
Billionaire tech mogul Elon Musk met with House Republicans Wednesday night to update them on work done by the Department of Government Efficiency (DOGE), as the newly created group takes ...The Hill - 4h -
Is Social Security money going to 'millions' of people listed as old as 149?
Trump drew laughs during his congressional address Tuesday when he alleged that the Social Security Administration (SSA) had millions of beneficiaries listed at 140 years of age and older. But is ...The Hill - 4h -
GOP lawmaker holding town hall despite advice to avoid them: 'I trust my constituents'
Rep. Chuck Edwards (R-N.C.) said Wednesday he’s holding a town hall despite House Republicans being recently pushed to avoid in-person town halls and do phone or livestreamed ones instead. “I'm ...The Hill - 4h